1. Home
  2. MAS vs MEDP Comparison

MAS vs MEDP Comparison

Compare MAS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Masco Corporation

MAS

Masco Corporation

HOLD

Current Price

$73.34

Market Cap

15.7B

Sector

Industrials

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$576.24

Market Cap

15.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAS
MEDP
Founded
1929
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
15.4B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
MAS
MEDP
Price
$73.34
$576.24
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$80.13
$473.17
AVG Volume (30 Days)
2.5M
382.8K
Earning Date
04-22-2026
04-22-2026
Dividend Yield
1.80%
N/A
EPS Growth
2.66
20.98
EPS
1.05
8.53
Revenue
$7,562,000,000.00
N/A
Revenue This Year
$2.70
$13.19
Revenue Next Year
$3.40
$7.75
P/E Ratio
$68.08
$67.66
Revenue Growth
N/A
N/A
52 Week Low
$58.16
$373.00
52 Week High
$83.64
$677.90

Technical Indicators

Market Signals
Indicator
MAS
MEDP
Relative Strength Index (RSI) 43.58 60.21
Support Level $63.06 $568.34
Resistance Level $75.59 $622.32
Average True Range (ATR) 2.21 22.71
MACD -0.96 -0.42
Stochastic Oscillator 20.22 36.96

Price Performance

Historical Comparison
MAS
MEDP

About MAS Masco Corporation

Masco is a global manufacturer of branded home improvement products, with a focus on plumbing fixtures (70% of revenue) and decorative architectural coatings (30% of revenue). The company primarily serves the repair and remodel market, with products such as faucets, showerheads, and paint sold through retail, wholesale, and e-commerce channels. Its portfolio includes well-known brands such as Delta, Hansgrohe, and Behr.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: